(technologies available for licensing)
Note: Links to Patents may require a browser newer than Internet Explorer 9, such as Chrome, Safari, Firefox, Edge, or Internet Explorer 11| TECH ID | TITLE | LEAD INVENTOR | CONTACT |
|---|---|---|---|
|
01-04 |
FC-muMCL1 murine mantle cell lymphoma model cell line |
Mitchell Smith |
|
|
01-21 |
N38-2C12/Va14+ T-cell hybridoma |
Kyoko Hayakawa |
|
|
01-22
|
N38-2C12/ Bv8.2 T-cell hybridoma |
Kyoko Hayakawa |
|
|
03-21 |
OVCAR-3 ovarian carcinoma cell line from a patient refractory to cisplatin |
Thomas Hamilton |
|
|
03-22 |
OVCAR-4 ovarian carcinoma cell line from a patient refractory to cisplatin |
Thomas Hamilton |
|
|
03-23 |
OVCAR-5 ovarian carcinoma cell line from untreated advanced tumor |
Thomas Hamilton |
|
|
03-26 |
A2780 ovarian cancer cell line (cisplatin sensitive) derived from patient prior to treatment
|
Thomas Hamilton |
|
|
03-32R |
MOVCAR cell lines |
Denise Connolly |
|
|
04-30 |
A2780/CP70 and CP30 cisplatin-resistant cell lines |
Thomas Hamilton |
|
|
05-18 |
Mesothelioma cell lines |
Joseph Testa |
|
|
07-14 |
PE01 human ovarian cancer cell line
|
Thomas Hamilton |
|
|
07-28 |
N38-3C3 NK T-cell hybridoma |
Kyoko Hayakawa |
|
|
95-13 |
HepAD38: tet-inducible HBV expression cell line |
Christoph Seeger |
|
|
120-RK |
Inducible HeLa TI-C GFP cells |
Richard Katz |
|
|
133-JR |
bsMCF: triple-negative breast cancer, Boyden chamber-selected tumorigenic cells |
Jose Russo |
|
|
134-JR |
trMCF: triple-negative breast cancer, estradiol-transformed cells |
Jose Russo |
|
|
150-WM |
LMH-D2 duck hepatitis B virus-expressing cell line
|
William Mason |
|
|
156-KH |
N37-1A12 T-cell hybridoma |
Kyoko Hayakawa |
|
|
191-CS |
Dstet5 cells |
Christoph Seeger |
|
|
249-JT |
Murine Thymic Lymphoma cells from Lck-Akt2 mice |
Joseph Testa |
|
|
263-DB |
Liposarcoma cell line LS2
|
Margaret von Mehren |
|
|
272-JT |
APPL1KO/WT MEF (murine embryonic fibroblasts) |
Joseph Testa |
|
|
295-CS |
HeLa HCV replicon |
Christoph Seeger |
|
|
310-MC |
Inflammatory breast cancer cell line FC-IBC02 |
Massimo Cristofanilli |
|
|
344-JR |
T4 cell line
|
Jose Russo |
|
|
353-DW |
Scid.adh: a thymic cell line that mimics T-cell development invitro |
David Wiest |
|
|
379-CS |
NTCP-HepG2 cell line |
Christoph Seeger |
|
|
382-CS |
NTCP-Cas9-HepG2 cell line
|
Christoph Seeger |
|
|
384-CS |
Hep AD38-Cas9 cell line
|
Christoph Seeger |
|
|
451-HB |
HEK293-MRP3 cells
|
Elizabeth Hopper-Borge |
|
|
452-HB |
HEK293-pcDNA Vector control cell line for MRP cells
|
Elizabeth Hopper-Borge |
|
|
453-HB |
HEK293-MRP7-C17 cells |
Elizabeth Hopper-Borge |
|
|
454-HB |
MEF 405 (MRP -/-, Pgp -/-) cells |
Elizabeth Hopper-Borge |
|
|
455-HB |
MEF 205 (MRP +/+, Pgp -/-) cells |
Elizabeth Hopper-Borge |
|
|
456-HB |
HEK293-MRP7-C18 cells |
Elizabeth Hopper-Borge |
|
|
457-HB |
MEF 237 (MRP -/-, Pgp +/+) cells |
Elizabeth Hopper-Borge |
|
|
535-HB |
Wild type (WT) mouse embryonic fibroblasts (MEFs): control for 454-HB;455-HB and 457-HB |
Elizabeth Hopper-Borge |
|
|
458-JR |
LmMCF cell line: triple-negative breast cancer cells derived from lung metastasis of bsMCF cells |
Jose Russo |
|
|
459-JR |
XtMCF cell line: triple-negative breast cancer cells derived from xenograft of bsMCF cells |
Jose Russo |
|
|
468-SA |
EBV-B cell line from a patient with renal cancer carrying mutation in the intronic region of RRM2B gene |
Sanjeevani Arora |
|
|
478-LW |
B16BL6-D5-HER2 cell line |
Louis Weiner |
|
|
503-MC |
EMF-011 cell line from patient with inflammatory breast cancer |
Massimo Cristofanilli |
|
|
504-AKS |
BEAS-2B-CSC 1196 xenograft-derived human bronchial epithelial cells (non-tumor derived) |
Andres Klein-Szanto |
|
|
505-AKS |
BEAS-2B-BW 1799 xenograft-derived human bronchial epithelial cells (control) |
Andres Klein-Szanto |
|
|
506-AKS |
BEAS-2B-CSC 1198 xenograft-derived human bronchial epithelial cells (non-tumor derived) |
Andres Klein-Szanto |
|
|
507-AKS |
BEAS-2B-CSC 1170-I xenograft-derived human bronchial epithelial cells (tumor derived) |
Andres Klein-Szanto |
|
|
525-EC |
Immortalized human pancreatic cancer-associated fibroblasts engineered to limit alpha 5 integrin expression |
Edna Cukierman |
|
|
526-EC |
Immortalized human pancreatic cancer-associated fibroblasts engineered to limit αV integrin expression |
Edna Cukierman |
|
|
527-EC |
Immortalized human pancreatic cancer-associated fibroblasts engineered to limit β3 integrin expression |
Edna Cukierman |
|
|
528-EC |
Immortalized human pancreatic cancer-associated fibroblasts engineered to limit β5 integrin expression |
Edna Cukierman |
|
|
529-EC |
Immortalized human pancreatic cancer-adjacent fibroblastic cells engineered to limit α5 integrin expression |
Edna Cukierman |
|
|
530-EC |
Immortalized human pancreatic cancer-adjacent fibroblastic cells engineered to limit αV integrin expression |
Edna Cukierman |
|
|
531-EC |
Immortalized human pancreatic cancer-adjacent fibroblastic cells engineered to limit β3 integrin expression |
Edna Cukierman |
|
|
532-EC |
Immortalized human pancreatic cancer-adjacent fibroblastic cells engineered to limit β5 integrin expression |
Edna Cukierman |
|
|
537-DC |
MOVCAR cell lines |
Denise Connolly |
|
|
540-KC |
SKOV3 cells expressing high levels of SLAMF7 |
Kerry Campbell |
|
|
556-IA |
KPC3 murine PDAC cell lines |
Igor Astsaturov |
|
|
557-IA |
KPC4b murine PDAC cell lines |
Igor Astsaturov |